Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334–57. https://doi.org/10.1161/HYPERTENSIONAHA.120.15026 Epub 2020 May 6. PMID: 32370572.
Wang C, Yuan Y, Zheng M, et al. Association of age of onset of hypertension with cardiovascular diseases and mortality. J Am Coll. 2020;75(23):2921–30. https://doi.org/10.1016/j.jacc.2020.04.038.
Chow CK, Gupta R. Blood pressure control: a challenge to global health systems. Lancet. 2019;394(10199):613–5. Available from. https://doi.org/10.1016/S0140-6736(19)31293-0.
Wyss F, Coca A, Lopez-Jaramillo P, Ponte-Negretti C. Task force for the management of arterial hypertension of the Interamerican Society of Cardiology (IASC); Reviewers from European Society of Hypertension (ESH), Latin-American Society of Hypertension (LASH), Spanish Society of Cardiology (SSC). Position statement of the Interamerican Society of Cardiology (IASC) on the current guidelines for the prevention, diagnosis and treatment of arterial hypertension 2017-2020. Int J Cardiol Hypertens. 2020;6:100041. https://doi.org/10.1016/j.ijchy.2020.100041 PMID: 33447767; PMCID: PMC7803017.
Luo D, Cheng Y, Zhang H, Ba M, Chen P, Li H, et al. Association between high blood pressure and long term cardiovascular events in young adults: systematic review and meta-analysis. BMJ. 2020;370:m3222. https://doi.org/10.1136/bmj.m3222 PMID: 32907799; PMCID: PMC7478061.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560–72. https://doi.org/10.1001/jama.289.19.2560.
Tocci G, Presta V, Citoni B, Figliuzzi I, Bianchi F, Ferrucci A, et al. Blood pressure target achievement under monotherapy: a real-life appraisal. High Blood Press Cardiovasc Prev. 2020;27(6):587–96. https://doi.org/10.1007/s40292-020-00420-y.
Tocci G, Presta V, Ferri C, Redon J, Volpe M. Blood pressure targets achievement according to 2018 ESC/ESH guidelines in three European excellence centers for hypertension. High Blood Press Cardiovasc Prev. 2020;27:51–9.
Bhatt LK, Selokar I, Raut D, Hussain T. Novel targets for hypertension drug discovery. Curr Hypertens Rep. 2021;23:19.
Rysz J, Franczyk B, Rysz-Górzy ´nska M, Gluba-Brzózka A. Pharmacogenomics of hypertension treatment. Int J Mol Sci. 2020;21:4709. https://doi.org/10.3390/ijms21134709.
Gong Y, McDonough CW, Wang Z, Hou W, Cooper-DeHoff RM, Langaee TY, et al. Hypertension susceptibility loci and blood pressure response to antihypertensives: results from the pharmacogenomic evaluation of antihypertensive responses study. Circ Cardiovasc Genet. 2012;5(6):686–91. https://doi.org/10.1161/CIRCGENETICS.112.964080.
Kato N, Takeuchi F, Tabara Y, Kelly TN, Go MJ, Sim X, et al. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians. Nat Genet. 2011;43(6):531–8. https://doi.org/10.1038/ng.834.
Lu X, Wang L, Lin X, Huang J, Charles Gu C, He M, et al. Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. Hum Mol Genet. 2015;24(3):865–74. https://doi.org/10.1093/hmg/ddu478.
Wang J, Xiong X. Evidence-based Chinese medicine for hypertension, evidence-based complementary and alternative medicine. eCAM. 2013;(2013):978398.
Xiong X, Yang X, Liu W, Chu F, Wang P, Wang J. Trends in the treatment of hypertension from the perspective of traditional Chinese medicine, evidence-based complementary alternative medicine. eCAM. 2013;275279.
Luo L-f, Wu W-h, Zhou Y-j, Yan J, Yang G-p, Ouyang D. Antihypertensive effect of Eucommia ulmoides Oliv, extracts in spontaneously hypertensive rats. J Ethnopharmacol. 2010;129(2):238–43. https://doi.org/10.1016/j.jep.2010.03.019.
Yao Y, Wang Y, Zhang Y, Liu C. Klotho ameliorates oxidized low-density lipoprotein (ox-LDL)-induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathways. Lipids Health Dis. 2017;16(1):77. https://doi.org/10.1186/s12944-017-0447-0.
He K, Li X, Chen X, Ye X, Huang J, Jin Y, et al. Evaluation of antidiabetic potential of selected traditional Chinese medicines in STZ-induced diabetic mice. J Ethnopharmacol. 2011;137(3):1135–42. https://doi.org/10.1016/j.jep.2011.07.033.
Dai X, Shulan S, Cai H, Wei D, Yan H, Zheng T, et al. Protective effects of total glycoside from Rehmannia glutinosa leaves on diabetic nephropathy rats via regulating the metabolic profiling and modulating the TGF-β1 and wnt/β-Catenin signaling pathway. Front Pharmacol. 2018;9:1012. https://doi.org/10.3389/fphar.2018.01012.
Ren L, Xu Y, Qin G, Liu C, Wang S. Effects of water extracts of Rehmannia glutinosa on antioxidant system of Nrf2 in paraquat-induced insulin resistance diabetic rat model. Exp Ther Med. 2017;14(6):5847–50. https://doi.org/10.3892/etm.2017.5302.
Duan X, Wang W, Liu X, Yan H, Dai R, Lin Q. Neuroprotective effect of ethyl acetate extract from gastrodia elata against transient focal cerebral ischemia in rats induced by middle cerebral artery occlusion. J Tradit Chin Med. 2015;35(6):671–8. https://doi.org/10.1016/S0254-6272(15)30158-8.
Kho MC, Lee YJ, Cha JD, Choi KM, Kang DG, Ho SL. Gastrodia elata ameliorates high-fructose diet-induced lipid metabolism and endothelial dysfunction, evidence-based complementary alternative medicine. eCAM. 2014;2014:101624.
Liu Y, Gao J, Peng M, Meng H, Ma H, Cai P, et al. A review on central nervous system effects of Gastrodin. Front Pharmacol. 2018;2(9):24. https://doi.org/10.3389/fphar.2018.00024.
Kim H-L, Jeon Y-D, Park J, Rim H-K, Jeong M-Y, Lim H, et al. Corni fructus containing formulation attenuates weight gain in mice with diet-induced obesity and regulates adipogenesis through AMPK. Evid Complement Alternat Med. 2013;2013:423741.
Wang D, Li C, Fan W, Yi T, Wei A, Ma Y. Hypoglycemic and hypolipidemic effects of a polysaccharide from Fructus Corni in streptozotocin-induced diabetic rats. Int J Biol Macromol. 2019;133:420–7. https://doi.org/10.1016/j.ijbiomac.2019.04.160.
Chen C-C, Hsu C-Y, Chen C-Y, Liu H-K. Fructus Corni suppresses hepatic gluconeogenesis related gene transcription, enhances glucose responsiveness of pancreatic beta-cells, and prevents toxin induced beta-cell death. J. Ethnopharmacol. 2008;117(3):483–90. https://doi.org/10.1016/j.jep.2008.02.032.
Gao D, Li Q, Gao Z, Wang L. Antidiabetic effects of Corni Fructus extract in streptozotocin-induced diabetic rats. Yonsei Med J. 2012;53(4):691–700. https://doi.org/10.3349/ymj.2012.53.4.691.
Park CH, Noh JS, Park JC, Yokozawa T. Beneficial effect of 7-O-galloyl-D-sedoheptulose, a polyphenol isolated from corni fructus, against diabetes-induced alterations in kidney and adipose tissue of type 2 diabetic db/db mice, Evidence-based complementary alternative medicine. eCAM. 2013;2013:736856.
Do TH, Trung TN, Hien TT, Dao TT, Yim N, Ngoc TM, et al. Selected compounds derived from Moutan Cortex stimulated glucose uptake and glycogen synthesis via AMPK activation in human HepG2 cells. J Ethnopharmacol. 2010;131(2):417–24.
Chen J, Hou X-F, Wang G, Zhong Q-X, Liu Y, Qiu H-H, et al. Terpene glycoside component from Moutan Cortex ameliorates diabetic nephropathy by regulating endoplasmic reticulum stress-related inflammatory responses. J Ethnopharmacol. 2016;193:433–44. https://doi.org/10.1016/j.jep.2016.09.043.
Dan H, Wu J, Peng M, Hu X, Song C, Zhou Z, et al. Hypolipidemic effects of Alismatis rhizome on lipid profile in mice fed high-fat diet. Saudi Med J. 2011;32(7):701–7.
Zhou X, Ren Q, Wang B, Fang G, Ling Y, Li X. Alisol a 24-acetate isolated from the alismatis rhizoma improves hepatic lipid deposition in hyperlipidemic mice by ABCA1/ABCG1 pathway. J Nanosci Nanotechno. 2019;19(9):5496–502. https://doi.org/10.1166/jnn.2019.16592.
Ho C, Gao Y, Zheng D, Liu Y, Shan S, Fang B, et al. Alisol A attenuates highfat-diet-induced obesity and metabolic disorders via the AMPK/ACC/SREBP-1c pathway. J Cell Mol Med. 2019;23(8):5108–18. https://doi.org/10.1111/jcmm.14380.
Chen YB, Dong YH. Clinical effect and pharmacological analysis of panax notoginseng saponins in the treatment of hyperlipidmia. China Med Pharm. 2006;6(139):51–3.
Xue-Jun DU, Lei Y, Yang J. Effects of Radix ginseng and Radix notoginseng formula on expressions of vascular endothelial growth factor receptor-2 and hypoxia-inducible factor-1alpha in ischemic myocardium of rats with acute myocardial infarction. Zhong Xi Yi Jie He Xue Bao. 2010;8(6):548–53. https://doi.org/10.3736/jcim20100607.
Liu L-T, Zheng G-J, Zhang W-G, Guo G, Wu M. Clinical study on treatment of carotid atherosclerosis with extraction of polygoni cuspidati rhizoma et Radix and crataegi fructus: a randomized controlled trial. Zhongguo Zhong Yao Za Zhi. 2014;39(6):1115–9.
Dalli E, Colomer E, Tormos MC, Cosín-Sales J, Milara J, Esteban E, et al. Crataegus laevigata decreases neutrophil elastase and has hypolipidemic effect: a randomized, double-blind, placebo-controlled trial. Phytomedicine. 2011;18:769–75.
Yang XC, Xiong XJ, Wang J. Clinical observation of 108 cases of primary hypertension treated with bu shen jiang ya therapy. World J Integr Traditional Western Med. 2014;10:1083–7.
Wang J, Xiong X. Current situation and perspectives of clinical study in integrative medicine in china, Evidence-based complementary alternative medicine. eCAM. 2012;2012:268542.
Wang J, Xiong X, Liu W. Traditional chinese medicine syndromes for essential hypertension: a literature analysis of 13,272 patients, evidence-based complementary and alternative medicine. eCAM. 2014;2014:418206–19. https://doi.org/10.1155/2014/418206.
Liu W, Wang J, Xiong XJ, Yang XC. Experimental study of bu shen jiang ya decoction on acute toxicology. Beijing J Tridit Chin Med. 2013;32:647–9.
Xiong X, Yang X, Duan L, Liu W, Zhang Y, Liu Y, et al. Traditional Chinese medicine suppresses left ventricular hypertrophy by targeting extracellular signal-regulated kinases signaling pathway in spontaneously hypertensive rats. Sci Rep. 2017;7(1):42965. https://doi.org/10.1038/srep42965.
Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63(8):e1–e37. https://doi.org/10.1016/j.jclinepi.2010.03.004.
Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P, for the CONSORT NPT Group. CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med. 2017;167(1):40–7. https://doi.org/10.7326/M17-0046.
Chan AW, Tetzlaff JM, Gøtzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials [J]. BMJ. 2013;346(jan08 15):e7586. https://doi.org/10.1136/bmj.e7586.
Liu J. Highlights of the 2018 Chinese hypertension guidelines. Clin Hypertens. 2020;26:8. https://doi.org/10.1186/s40885-020-00141-3 PMID: 32377372; PMCID: PMC7193361.
World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ. 2001;79(4):373–4.
Switula D. Principles of good clinical practice (GCP) in clinical research. Sci Eng Ethics. 2000;6(1):71–7. https://doi.org/10.1007/s11948-000-0025-z.
Zheng XY. Guiding principles for clinical research of new Chinese medicines. China Med Sci Technol Press. 2002;4:73–7.
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. https://doi.org/10.1016/0165-1781(89)90047-4.
Insana SP, Hall M, Buysse DJ, Germain A. Validation of the Pittsburgh Sleep Quality Index Addendum for posttraumatic stress disorder (PSQI-A) in U.S. male military veterans. J Trauma Stress. 2013;26(2):192–200. https://doi.org/10.1002/jts.21793.
Wan X, Zh L, Liu JP. Estimation of sample size in clinical studies: (1) clinical trials. J Tradit Chin Med. 2017;48:504–7.
Ventura HO, Taler SJ, Strobeck JE. Hypertension as a hemodynamic disease: the role of impedance cardiography in diagnostic, prognostic, and therapeutic decision making. Am J Hypertens. 2005;18(2 Pt 2):26S–43S. https://doi.org/10.1016/j.amjhyper.2004.11.002.
Liu W, Li Y, Xiong X, Chen Y, Qiao L, Wang J, et al. Traditional Chinese medicine protects against hypertensive kidney injury in Dahl salt-sensitive rats by targeting transforming growth factor-β signaling pathway. Biomed Pharmacother. 2020;131:110746. https://doi.org/10.1016/j.biopha.2020.110746 Epub 2020 Sep 17. PMID: 33152915.
Yang X-c, Yun Z, Yongmei L, Wang J. Explore mechanism of Bushen Jiangya Decoction for hypertension based on network pharmacology. Chinses J Int Med Cardio-cerebrovasc Dis. 2021;19(2):197–205.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.